Literature DB >> 7744764

Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry.

T Kupke1, C Kempter, G Jung, F Götz.   

Abstract

The flavoprotein EpiD catalyzes the COOH-terminal oxidative decarboxylation of the lantibiotic precursor peptide EpiA. Variations of the COOH-terminal heptapeptide S1FNSYCC7 of EpiA were used for determining the substrate specificity of EpiD. When Cys7 was replaced by serine, cysteine-amide, homocysteine, or a thioether amino acid residue, no reaction with EpiD was observed. Heptapeptide libraries with one variable amino acid residue at positions 1-7 of the peptide substrate S1FNSYCC7 were incubated with EpiD, and the reaction products were identified by neutral loss mass spectrometry. When the penultimate cysteine residue Cys6 of the substrate peptide was replaced with Ser, Thr, Ala, or Val, the reaction still occurred. Tyr5 could be replaced with other hydrophobic amino acid residues. Mass spectrometry was used to compare the kinetics of the reaction of EpiD with various peptides. Peptide sequencing of the reaction products was performed by tandem mass spectrometry, confirming that the last cysteine residue was modified. The removal of the acid COOH-terminal carboxyl group was confirmed by determination of the isoelectric points of the reaction products. To study the interaction between EpiA and EpiD, EpiA was coupled to N-hydroxysuccinimide-activated Sepharose HiTrap material; EpiD was only retarded under reducing conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744764     DOI: 10.1074/jbc.270.19.11282

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin.

Authors:  Florian Majer; Dietmar G Schmid; Karsten Altena; Gabriele Bierbaum; Thomas Kupke
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

2.  Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.

Authors:  Raquel Regina Bonelli; Tanja Schneider; Hans-Georg Sahl; Imke Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 3.  Rings, radicals, and regeneration: the early years of a bioorganic laboratory.

Authors:  Wilfred A van der Donk
Journal:  J Org Chem       Date:  2006-12-22       Impact factor: 4.354

Review 4.  Post-translational modifications of lantibiotics.

Authors:  T Kupke; F Götz
Journal:  Antonie Van Leeuwenhoek       Date:  1996-02       Impact factor: 2.271

Review 5.  Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.

Authors:  Lindsay M Repka; Jonathan R Chekan; Satish K Nair; Wilfred A van der Donk
Journal:  Chem Rev       Date:  2017-01-30       Impact factor: 60.622

6.  Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.

Authors:  Jerome Escano; Akshaya Ravichandran; Bita Salamat; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

7.  Crystal structure of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide substrate.

Authors:  M Blaesse; T Kupke; R Huber; S Steinbacher
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

8.  The Radical S-Adenosyl-l-methionine Enzyme MftC Catalyzes an Oxidative Decarboxylation of the C-Terminus of the MftA Peptide.

Authors:  Nathan A Bruender; Vahe Bandarian
Journal:  Biochemistry       Date:  2016-05-13       Impact factor: 3.162

Review 9.  The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.

Authors:  G Bierbaum; F Götz; A Peschel; T Kupke; M van de Kamp; H G Sahl
Journal:  Antonie Van Leeuwenhoek       Date:  1996-02       Impact factor: 2.271

10.  Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli.

Authors:  Yanxiang Shi; Alejandro Bueno; Wilfred A van der Donk
Journal:  Chem Commun (Camb)       Date:  2012-11-18       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.